Non-Alcoholic Fatty Liver Disease: The Bile Acid-Activated Farnesoid X Receptor as an Emerging Treatment Target

Non-alcoholic fatty liver disease (NAFLD) is currently evolving as the most common liver disease worldwide. It may progress to liver cirrhosis and liver cancer and is poised to represent the most common indication for liver transplantation in the near future. The pathogenesis of NAFLD is multifactor...

Descripción completa

Detalles Bibliográficos
Autor principal: Fuchs, Michael
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi Publishing Corporation 2012
Materias:
Review Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3236512/
https://www.ncbi.nlm.nih.gov/pubmed/22187656
http://dx.doi.org/10.1155/2012/934396

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3236512/
https://www.ncbi.nlm.nih.gov/pubmed/22187656
http://dx.doi.org/10.1155/2012/934396

Ejemplares similares